 | • レポートコード：QY2108PAL5431 • 出版社/出版日：QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、162ページ • 納品方法：Eメール（納期：1日） • 産業分類：化学＆材料 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の当調査資料ではグローバルにおけるウシ血漿誘導体の市場規模（2016年-2027年）と動向についてまとめました。中国市場については主要プレイヤーの市場シェア、ウシ血漿誘導体の種類別市場規模（ウシ血清、FBS、ウシ血清アルブミン、フィブリノーゲン、タンパク質成分、その他）、用途別市場規模（科学研究、工業生産、飼料、その他）も掲載しています。他に、北米・アメリカ市場、ヨーロッパ市場、アジア太平洋・日本市場、中南米市場、中東・アフリカ市場の市場規模、グローバル市場機会・課題・リスク要因、バリューチェーン・販売チャネル、主要プレイヤーの情報なども掲載しています。 ・調査の概要 ・調査のサマリー ・世界のウシ血漿誘導体市場動向 ・グローバル主要プレイヤーの競争状況・市場シェア ・世界におけるウシ血漿誘導体の種類別市場規模（2016年-2027年）：ウシ血清、FBS、ウシ血清アルブミン、フィブリノーゲン、タンパク質成分、その他 ・世界におけるウシ血漿誘導体の用途別市場規模（2016年-2027年）：科学研究、工業生産、飼料、その他 ・ウシ血漿誘導体の中国市場分析 - ウシ血漿誘導体の中国市場規模（2016年-2027年） - 中国におけるウシ血漿誘導体の主要プレイヤー別市場シェア - 中国におけるウシ血漿誘導体の種類別市場規模：ウシ血清、FBS、ウシ血清アルブミン、フィブリノーゲン、タンパク質成分、その他 - 中国におけるウシ血漿誘導体の用途別市場規模：科学研究、工業生産、飼料、その他 ・ウシ血漿誘導体の北米市場（2016年-2027年） ・ウシ血漿誘導体のヨーロッパ市場（2016年-2027年） ・ウシ血漿誘導体のアジア太平洋市場（2016年-2027年） ・ウシ血漿誘導体の中南米市場（2016年-2027年） ・ウシ血漿誘導体の中東・アフリカ市場（2016年-2027年） ・主要プレイヤーの情報：Thermo Fisher、GE Healthcare、Merck (Sigma-Aldrich)、Moregate BioTech、Gemini、Atlanta Biologicals、Tissue Culture Biologicals、Bovogen、Biowest、Internegocios、RMBIO、Biological Industries、VWR、Corning、Serana、Lanzhou Minhai、Zhejiang Tianhang Biotechnology、ExCell Bio、Jin Yuan Kang、American Protein Company、Sonac ・市場機会・課題・リスク要因分析 ・バリューチェーン・販売チャネル分析 ・... |
This report studies the Bovine Blood Plasma Derivatives market, from angles of Company, regions, product types and end industries, to analyze the status and the future. This report covers different types of bovine blood plasma derivatives.
Global Bovine Blood Plasma Derivatives key players include Thermo Fisher, GE Healthcare, Merck (Sigma-Aldrich), etc. Global top three manufacturers hold a share about 30%.
North America is the largest market, with a share about 40%, followed by Europe, and Asia Pacific, both have a share over 45 percent.
In terms of product, FBS is the largest segment, with a share over 65%. And in terms of application, the largest application is Scientific Research, followed by Industrial Production, Feed, etc.
Market Analysis and Insights: Global and China Bovine Blood Plasma Derivatives Market
This report focuses on global and China Bovine Blood Plasma Derivatives market.
In 2020, the global Bovine Blood Plasma Derivatives market size was US$ 1802 million and it is expected to reach US$ 2912.4 million by the end of 2027, with a CAGR of 7.2% during 2021-2027. In China the Bovine Blood Plasma Derivatives market size is expected to grow from US$ XX million in 2020 to US$ XX million by 2027, at a CAGR of XX% during the forecast period.
Global Bovine Blood Plasma Derivatives Scope and Market Size
Bovine Blood Plasma Derivatives market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Bovine Blood Plasma Derivatives market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2016-2027.
For China market, this report focuses on the Bovine Blood Plasma Derivatives market size by players, by Type, and by Application, for the period 2016-2027. The key players include the global and local players which play important roles in China.
Segment by Type
Bovine Serum
FBS
Bovine Serum Albumin
Fibrinogen
Protein Ingredient
Other
Segment by Application
Scientific Research
Industrial Production
Feed
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
By Company
Thermo Fisher
GE Healthcare
Merck (Sigma-Aldrich)
Moregate BioTech
Gemini
Atlanta Biologicals
Tissue Culture Biologicals
Bovogen
Biowest
Internegocios
RMBIO
Biological Industries
VWR
Corning
Serana
Lanzhou Minhai
Zhejiang Tianhang Biotechnology
ExCell Bio
Jin Yuan Kang
American Protein Company
Sonac
1 Study Coverage
1.1 Bovine Blood Plasma Derivatives Product Introduction
1.2 Market by Type
1.2.1 Global Bovine Blood Plasma Derivatives Market Size Growth Rate by Type
1.2.2 Bovine Serum
1.2.3 FBS
1.2.4 Bovine Serum Albumin
1.2.5 Fibrinogen
1.2.6 Protein Ingredient
1.2.7 Other
1.3 Market by Application
1.3.1 Global Bovine Blood Plasma Derivatives Market Size Growth Rate by Application
1.3.2 Scientific Research
1.3.3 Industrial Production
1.3.4 Feed
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Bovine Blood Plasma Derivatives Market Size, Estimates and Forecasts
2.1.1 Global Bovine Blood Plasma Derivatives Revenue 2016-2027
2.1.2 Global Bovine Blood Plasma Derivatives Sales 2016-2027
2.2 Global Bovine Blood Plasma Derivatives, Market Size by Region: 2016 VS 2021 VS 2027
2.3 Bovine Blood Plasma Derivatives Historical Market Size by Region (2016-2021)
2.3.1 Global Bovine Blood Plasma Derivatives Retrospective Market Scenario in Sales by Region: 2016-2021
2.3.2 Global Bovine Blood Plasma Derivatives Retrospective Market Scenario in Revenue by Region: 2016-2021
2.4 Bovine Blood Plasma Derivatives Market Estimates and Projections by Region (2022-2027)
2.4.1 Global Bovine Blood Plasma Derivatives Sales Forecast by Region (2022-2027)
2.4.2 Global Bovine Blood Plasma Derivatives Revenue Forecast by Region (2022-2027)
3 Global Bovine Blood Plasma Derivatives Competitor Landscape by Players
3.1 Global Top Bovine Blood Plasma Derivatives Manufacturers by Sales
3.1.1 Global Bovine Blood Plasma Derivatives Sales by Manufacturer (2016-2021)
3.1.2 Global Bovine Blood Plasma Derivatives Sales Market Share by Manufacturer (2016-2021)
3.2 Global Top Bovine Blood Plasma Derivatives Manufacturers by Revenue
3.2.1 Key Bovine Blood Plasma Derivatives Manufacturers Covered: Ranking by Revenue
3.2.2 Global Bovine Blood Plasma Derivatives Revenue by Manufacturers (2016-2021)
3.2.3 Global Bovine Blood Plasma Derivatives Revenue Share by Manufacturers (2016-2021)
3.2.4 Global Bovine Blood Plasma Derivatives Market Concentration Ratio (CR5 and HHI) (2016-2021)
3.2.5 Global Top 10 and Top 5 Companies by Bovine Blood Plasma Derivatives Revenue in 2020
3.2.6 Global Bovine Blood Plasma Derivatives Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Global Bovine Blood Plasma Derivatives Price by Manufacturers
3.4 Global Bovine Blood Plasma Derivatives Manufacturing Base Distribution, Product Types
3.4.1 Bovine Blood Plasma Derivatives Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Bovine Blood Plasma Derivatives Product Type
3.4.3 Date of International Manufacturers Enter into Bovine Blood Plasma Derivatives Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2016-2027)
4.1 Global Bovine Blood Plasma Derivatives Market Size by Type (2016-2021)
4.1.1 Global Bovine Blood Plasma Derivatives Sales by Type (2016-2021)
4.1.2 Global Bovine Blood Plasma Derivatives Revenue by Type (2016-2021)
4.1.3 Bovine Blood Plasma Derivatives Average Selling Price (ASP) by Type (2016-2021)
4.2 Global Bovine Blood Plasma Derivatives Market Size Forecast by Type (2022-2027)
4.2.1 Global Bovine Blood Plasma Derivatives Sales Forecast by Type (2022-2027)
4.2.2 Global Bovine Blood Plasma Derivatives Revenue Forecast by Type (2022-2027)
4.2.3 Bovine Blood Plasma Derivatives Average Selling Price (ASP) Forecast by Type (2022-2027)
5 Breakdown Data by Application (2016-2027)
5.1 Global Bovine Blood Plasma Derivatives Market Size by Application (2016-2021)
5.1.1 Global Bovine Blood Plasma Derivatives Sales by Application (2016-2021)
5.1.2 Global Bovine Blood Plasma Derivatives Revenue by Application (2016-2021)
5.1.3 Bovine Blood Plasma Derivatives Price by Application (2016-2021)
5.2 Bovine Blood Plasma Derivatives Market Size Forecast by Application (2022-2027)
5.2.1 Global Bovine Blood Plasma Derivatives Sales Forecast by Application (2022-2027)
5.2.2 Global Bovine Blood Plasma Derivatives Revenue Forecast by Application (2022-2027)
5.2.3 Global Bovine Blood Plasma Derivatives Price Forecast by Application (2022-2027)
6 China by Players, Type and Application
6.1 China Bovine Blood Plasma Derivatives Market Size YoY Growth 2016-2027
6.1.1 China Bovine Blood Plasma Derivatives Sales YoY Growth 2016-2027
6.1.2 China Bovine Blood Plasma Derivatives Revenue YoY Growth 2016-2027
6.1.3 China Bovine Blood Plasma Derivatives Market Share in Global Market 2016-2027
6.2 China Bovine Blood Plasma Derivatives Market Size by Players (International and Local Players)
6.2.1 China Top Bovine Blood Plasma Derivatives Players by Sales (2016-2021)
6.2.2 China Top Bovine Blood Plasma Derivatives Players by Revenue (2016-2021)
6.3 China Bovine Blood Plasma Derivatives Historic Market Review by Type (2016-2021)
6.3.1 China Bovine Blood Plasma Derivatives Sales Market Share by Type (2016-2021)
6.3.2 China Bovine Blood Plasma Derivatives Revenue Market Share by Type (2016-2021)
6.3.3 China Bovine Blood Plasma Derivatives Price by Type (2016-2021)
6.4 China Bovine Blood Plasma Derivatives Market Estimates and Forecasts by Type (2022-2027)
6.4.1 China Bovine Blood Plasma Derivatives Sales Forecast by Type (2022-2027)
6.4.2 China Bovine Blood Plasma Derivatives Revenue Forecast by Type (2022-2027)
6.4.3 China Bovine Blood Plasma Derivatives Price Forecast by Type (2022-2027)
6.5 China Bovine Blood Plasma Derivatives Historic Market Review by Application (2016-2021)
6.5.1 China Bovine Blood Plasma Derivatives Sales Market Share by Application (2016-2021)
6.5.2 China Bovine Blood Plasma Derivatives Revenue Market Share by Application (2016-2021)
6.5.3 China Bovine Blood Plasma Derivatives Price by Application (2016-2021)
6.6 China Bovine Blood Plasma Derivatives Market Estimates and Forecasts by Application (2022-2027)
6.6.1 China Bovine Blood Plasma Derivatives Sales Forecast by Application (2022-2027)
6.6.2 China Bovine Blood Plasma Derivatives Revenue Forecast by Application (2022-2027)
6.6.3 China Bovine Blood Plasma Derivatives Price Forecast by Application (2022-2027)
7 North America
7.1 North America Bovine Blood Plasma Derivatives Market Size YoY Growth 2016-2027
7.2 North America Bovine Blood Plasma Derivatives Market Facts & Figures by Country
7.2.1 North America Bovine Blood Plasma Derivatives Sales by Country (2016-2021)
7.2.2 North America Bovine Blood Plasma Derivatives Revenue by Country (2016-2021)
7.2.3 U.S.
7.2.4 Canada
8 Asia Pacific
8.1 Asia Pacific Bovine Blood Plasma Derivatives Market Size YoY Growth 2016-2027
8.2 Asia Pacific Bovine Blood Plasma Derivatives Market Facts & Figures by Region
8.2.1 Asia Pacific Bovine Blood Plasma Derivatives Sales by Region (2016-2021)
8.2.2 Asia Pacific Bovine Blood Plasma Derivatives Revenue by Region (2016-2021)
8.2.3 China
8.2.4 Japan
8.2.5 South Korea
8.2.6 India
8.2.7 Australia
8.2.8 Australia
8.2.9 Indonesia
8.2.10 Thailand
8.2.11 Malaysia
8.2.12 Philippines
8.2.13 Vietnam
9 Europe
9.1 Europe Bovine Blood Plasma Derivatives Market Size YoY Growth 2016-2027
9.2 Europe Bovine Blood Plasma Derivatives Market Facts & Figures by Country
9.2.1 Europe Bovine Blood Plasma Derivatives Sales by Country (2016-2021)
9.2.2 Europe Bovine Blood Plasma Derivatives Revenue by Country (2016-2021)
9.2.3 Germany
9.2.4 France
9.2.5 U.K.
9.2.6 Italy
10 Latin America
10.1 Latin America Bovine Blood Plasma Derivatives Market Size YoY Growth 2016-2027
10.2 Latin America Bovine Blood Plasma Derivatives Market Facts & Figures by Country
10.2.1 Latin America Bovine Blood Plasma Derivatives Sales by Country (2016-2021)
10.2.2 Latin America Bovine Blood Plasma Derivatives Revenue by Country (2016-2021)
10.2.3 Mexico
10.2.4 Brazil
10.2.5 Argentina
11 Middle East and Africa
11.1 Middle East and Africa Bovine Blood Plasma Derivatives Market Size YoY Growth 2016-2027
11.2 Middle East and Africa Bovine Blood Plasma Derivatives Market Facts & Figures by Country
11.2.1 Middle East and Africa Bovine Blood Plasma Derivatives Sales by Country (2016-2021)
11.2.2 Middle East and Africa Bovine Blood Plasma Derivatives Revenue by Country (2016-2021)
11.2.3 Turkey
11.2.4 Saudi Arabia
11.2.5 U.A.E
12 Company Profiles
12.1 Thermo Fisher
12.1.1 Thermo Fisher Corporation Information
12.1.2 Thermo Fisher Description and Business Overview
12.1.3 Thermo Fisher Bovine Blood Plasma Derivatives Sales, Revenue and Gross Margin (2016-2021)
12.1.4 Thermo Fisher Bovine Blood Plasma Derivatives Products Offered
12.1.5 Thermo Fisher Recent Development
12.2 GE Healthcare
12.2.1 GE Healthcare Corporation Information
12.2.2 GE Healthcare Description and Business Overview
12.2.3 GE Healthcare Bovine Blood Plasma Derivatives Sales, Revenue and Gross Margin (2016-2021)
12.2.4 GE Healthcare Bovine Blood Plasma Derivatives Products Offered
12.2.5 GE Healthcare Recent Development
12.3 Merck (Sigma-Aldrich)
12.3.1 Merck (Sigma-Aldrich) Corporation Information
12.3.2 Merck (Sigma-Aldrich) Description and Business Overview
12.3.3 Merck (Sigma-Aldrich) Bovine Blood Plasma Derivatives Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Merck (Sigma-Aldrich) Bovine Blood Plasma Derivatives Products Offered
12.3.5 Merck (Sigma-Aldrich) Recent Development
12.4 Moregate BioTech
12.4.1 Moregate BioTech Corporation Information
12.4.2 Moregate BioTech Description and Business Overview
12.4.3 Moregate BioTech Bovine Blood Plasma Derivatives Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Moregate BioTech Bovine Blood Plasma Derivatives Products Offered
12.4.5 Moregate BioTech Recent Development
12.5 Gemini
12.5.1 Gemini Corporation Information
12.5.2 Gemini Description and Business Overview
12.5.3 Gemini Bovine Blood Plasma Derivatives Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Gemini Bovine Blood Plasma Derivatives Products Offered
12.5.5 Gemini Recent Development
12.6 Atlanta Biologicals
12.6.1 Atlanta Biologicals Corporation Information
12.6.2 Atlanta Biologicals Description and Business Overview
12.6.3 Atlanta Biologicals Bovine Blood Plasma Derivatives Sales, Revenue and Gross Margin (2016-2021)
12.6.4 Atlanta Biologicals Bovine Blood Plasma Derivatives Products Offered
12.6.5 Atlanta Biologicals Recent Development
12.7 Tissue Culture Biologicals
12.7.1 Tissue Culture Biologicals Corporation Information
12.7.2 Tissue Culture Biologicals Description and Business Overview
12.7.3 Tissue Culture Biologicals Bovine Blood Plasma Derivatives Sales, Revenue and Gross Margin (2016-2021)
12.7.4 Tissue Culture Biologicals Bovine Blood Plasma Derivatives Products Offered
12.7.5 Tissue Culture Biologicals Recent Development
12.8 Bovogen
12.8.1 Bovogen Corporation Information
12.8.2 Bovogen Description and Business Overview
12.8.3 Bovogen Bovine Blood Plasma Derivatives Sales, Revenue and Gross Margin (2016-2021)
12.8.4 Bovogen Bovine Blood Plasma Derivatives Products Offered
12.8.5 Bovogen Recent Development
12.9 Biowest
12.9.1 Biowest Corporation Information
12.9.2 Biowest Description and Business Overview
12.9.3 Biowest Bovine Blood Plasma Derivatives Sales, Revenue and Gross Margin (2016-2021)
12.9.4 Biowest Bovine Blood Plasma Derivatives Products Offered
12.9.5 Biowest Recent Development
12.10 Internegocios
12.10.1 Internegocios Corporation Information
12.10.2 Internegocios Description and Business Overview
12.10.3 Internegocios Bovine Blood Plasma Derivatives Sales, Revenue and Gross Margin (2016-2021)
12.10.4 Internegocios Bovine Blood Plasma Derivatives Products Offered
12.10.5 Internegocios Recent Development
12.11 Thermo Fisher
12.11.1 Thermo Fisher Corporation Information
12.11.2 Thermo Fisher Description and Business Overview
12.11.3 Thermo Fisher Bovine Blood Plasma Derivatives Sales, Revenue and Gross Margin (2016-2021)
12.11.4 Thermo Fisher Bovine Blood Plasma Derivatives Products Offered
12.11.5 Thermo Fisher Recent Development
12.12 Biological Industries
12.12.1 Biological Industries Corporation Information
12.12.2 Biological Industries Description and Business Overview
12.12.3 Biological Industries Bovine Blood Plasma Derivatives Sales, Revenue and Gross Margin (2016-2021)
12.12.4 Biological Industries Products Offered
12.12.5 Biological Industries Recent Development
12.13 VWR
12.13.1 VWR Corporation Information
12.13.2 VWR Description and Business Overview
12.13.3 VWR Bovine Blood Plasma Derivatives Sales, Revenue and Gross Margin (2016-2021)
12.13.4 VWR Products Offered
12.13.5 VWR Recent Development
12.14 Corning
12.14.1 Corning Corporation Information
12.14.2 Corning Description and Business Overview
12.14.3 Corning Bovine Blood Plasma Derivatives Sales, Revenue and Gross Margin (2016-2021)
12.14.4 Corning Products Offered
12.14.5 Corning Recent Development
12.15 Serana
12.15.1 Serana Corporation Information
12.15.2 Serana Description and Business Overview
12.15.3 Serana Bovine Blood Plasma Derivatives Sales, Revenue and Gross Margin (2016-2021)
12.15.4 Serana Products Offered
12.15.5 Serana Recent Development
12.16 Lanzhou Minhai
12.16.1 Lanzhou Minhai Corporation Information
12.16.2 Lanzhou Minhai Description and Business Overview
12.16.3 Lanzhou Minhai Bovine Blood Plasma Derivatives Sales, Revenue and Gross Margin (2016-2021)
12.16.4 Lanzhou Minhai Products Offered
12.16.5 Lanzhou Minhai Recent Development
12.17 Zhejiang Tianhang Biotechnology
12.17.1 Zhejiang Tianhang Biotechnology Corporation Information
12.17.2 Zhejiang Tianhang Biotechnology Description and Business Overview
12.17.3 Zhejiang Tianhang Biotechnology Bovine Blood Plasma Derivatives Sales, Revenue and Gross Margin (2016-2021)
12.17.4 Zhejiang Tianhang Biotechnology Products Offered
12.17.5 Zhejiang Tianhang Biotechnology Recent Development
12.18 ExCell Bio
12.18.1 ExCell Bio Corporation Information
12.18.2 ExCell Bio Description and Business Overview
12.18.3 ExCell Bio Bovine Blood Plasma Derivatives Sales, Revenue and Gross Margin (2016-2021)
12.18.4 ExCell Bio Products Offered
12.18.5 ExCell Bio Recent Development
12.19 Jin Yuan Kang
12.19.1 Jin Yuan Kang Corporation Information
12.19.2 Jin Yuan Kang Description and Business Overview
12.19.3 Jin Yuan Kang Bovine Blood Plasma Derivatives Sales, Revenue and Gross Margin (2016-2021)
12.19.4 Jin Yuan Kang Products Offered
12.19.5 Jin Yuan Kang Recent Development
12.20 American Protein Company
12.20.1 American Protein Company Corporation Information
12.20.2 American Protein Company Description and Business Overview
12.20.3 American Protein Company Bovine Blood Plasma Derivatives Sales, Revenue and Gross Margin (2016-2021)
12.20.4 American Protein Company Products Offered
12.20.5 American Protein Company Recent Development
12.21 Sonac
12.21.1 Sonac Corporation Information
12.21.2 Sonac Description and Business Overview
12.21.3 Sonac Bovine Blood Plasma Derivatives Sales, Revenue and Gross Margin (2016-2021)
12.21.4 Sonac Products Offered
12.21.5 Sonac Recent Development
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Bovine Blood Plasma Derivatives Industry Trends
13.2 Bovine Blood Plasma Derivatives Market Drivers
13.3 Bovine Blood Plasma Derivatives Market Challenges
13.4 Bovine Blood Plasma Derivatives Market Restraints
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Bovine Blood Plasma Derivatives Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Table 1. Global Bovine Blood Plasma Derivatives Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million)
Table 2. Major Manufacturers of Bovine Serum
Table 3. Major Manufacturers of FBS
Table 4. Major Manufacturers of Bovine Serum Albumin
Table 5. Major Manufacturers of Fibrinogen
Table 6. Major Manufacturers of Protein Ingredient
Table 7. Major Manufacturers of Other
Table 8. Global Bovine Blood Plasma Derivatives Market Size Growth Rate by Application (2021-2027) & (K Liters)
Table 9. Global Bovine Blood Plasma Derivatives Market Size by Region (K Liters) & (US$ Million), 2016 VS 2021 VS 2027
Table 10. Global Bovine Blood Plasma Derivatives Sales by Regions (2016-2021) & (K Liters)
Table 11. Global Bovine Blood Plasma Derivatives Sales Market Share by Regions (2016-2021)
Table 12. Global Bovine Blood Plasma Derivatives Revenue by Regions (2016-2021) & (US$ Million)
Table 13. Global Bovine Blood Plasma Derivatives Sales Forecast by Region (2022-2027) & (K Liters)
Table 14. Global Bovine Blood Plasma Derivatives Sales Market Share Forecast by Region (2022-2027)
Table 15. Global Bovine Blood Plasma Derivatives Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 16. Global Bovine Blood Plasma Derivatives Revenue Market Share Forecast by Region (2022-2027)
Table 17. Global Bovine Blood Plasma Derivatives Sales by Manufacturers (2016-2021) (K Liters)
Table 18. Global Bovine Blood Plasma Derivatives Sales Share by Manufacturers (2016-2021)
Table 19. Ranking of Global Top Bovine Blood Plasma Derivatives Manufacturers by Revenue (US$ Million) in 2020
Table 20. Bovine Blood Plasma Derivatives Revenue by Manufacturers (2016-2021) (US$ Million)
Table 21. Bovine Blood Plasma Derivatives Revenue Share by Manufacturers (2016-2021)
Table 22. Global Bovine Blood Plasma Derivatives Manufacturers Market Concentration Ratio (CR5 and HHI) & (2016-2021)
Table 23. Global Bovine Blood Plasma Derivatives by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Bovine Blood Plasma Derivatives as of 2020)
Table 24. Key Manufacturers Bovine Blood Plasma Derivatives Price (2016-2021) (USD/L)
Table 25. Bovine Blood Plasma Derivatives Manufacturers Manufacturing Base Distribution and Headquarters
Table 26. Manufacturers Bovine Blood Plasma Derivatives Product Type
Table 27. Date of International Manufacturers Enter into Bovine Blood Plasma Derivatives Market
Table 28. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 29. Global Bovine Blood Plasma Derivatives Sales by Type (2016-2021) (K Liters)
Table 30. Global Bovine Blood Plasma Derivatives Sales Share by Type (2016-2021)
Table 31. Global Bovine Blood Plasma Derivatives Revenue by Type (2016-2021) (US$ Million)
Table 32. Global Bovine Blood Plasma Derivatives Revenue Share by Type (2016-2021)
Table 33. Bovine Blood Plasma Derivatives Average Selling Price (ASP) by Type (2016-2021) & (USD/L)
Table 34. Global Bovine Blood Plasma Derivatives Sales Forecast by Type (2022-2027) & (K Liters)
Table 35. Global Bovine Blood Plasma Derivatives Sales Market Share Forecast by Type (2022-2027)
Table 36. Global Bovine Blood Plasma Derivatives Revenue Forecast V (2022-2027) & (US$ Million)
Table 37. Global Bovine Blood Plasma Derivatives Revenue Market Share Forecast by Type (2022-2027)
Table 38. Global Bovine Blood Plasma Derivatives Average Selling Price (ASP) Forecast by Type (2022-2027) & (USD/L)
Table 39. Global Bovine Blood Plasma Derivatives Sales by Application (2016-2021) (K Liters)
Table 40. Global Bovine Blood Plasma Derivatives Sales Share by Application (2016-2021)
Table 41. Global Bovine Blood Plasma Derivatives Revenue by Application (2016-2021) (US$ Million)
Table 42. Global Bovine Blood Plasma Derivatives Revenue Share by Application (2016-2021)
Table 43. Bovine Blood Plasma Derivatives Average Selling Price (ASP) by Application (2016-2021) & (USD/L)
Table 44. Global Bovine Blood Plasma Derivatives Sales Forecast by Application (2022-2027) & (K Liters)
Table 45. Global Bovine Blood Plasma Derivatives Sales Market Share Forecast by Application (2022-2027)
Table 46. Global Bovine Blood Plasma Derivatives Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 47. Global Bovine Blood Plasma Derivatives Revenue Market Share Forecast by Application (2022-2027)
Table 48. Global Bovine Blood Plasma Derivatives Average Selling Price (ASP) Forecast by Application (2022-2027) & (USD/L)
Table 49. China Bovine Blood Plasma Derivatives Sales (K Liters) of Key Companies (2016-2021)
Table 50. China Bovine Blood Plasma Derivatives Sales Share by Company (2016-2021)
Table 51. China Bovine Blood Plasma Derivatives Revenue (US$ Million) by Company (2016-2021)
Table 52. China Bovine Blood Plasma Derivatives Revenue Share by Company (2016-2021)
Table 53. China Bovine Blood Plasma Derivatives Sales (K Liters) by Type (2016-2021)
Table 54. China Bovine Blood Plasma Derivatives Sales Share by Type (2016-2021)
Table 55. China Bovine Blood Plasma Derivatives Revenue (US$ Million) Market Share by Type (2016-2021)
Table 56. China Bovine Blood Plasma Derivatives Price (USD/L) by Type (2016-2021)
Table 57. China Bovine Blood Plasma Derivatives Sales (K Liters) by Type (2022-2027)
Table 58. China Bovine Blood Plasma Derivatives Sales Share by Type (2022-2027)
Table 59. China Bovine Blood Plasma Derivatives Revenue (US$ Million) Market Share by Type (2022-2027)
Table 60. China Bovine Blood Plasma Derivatives Revenue Share by Type (2022-2027)
Table 61. China Bovine Blood Plasma Derivatives Price (USD/L) by Type (2022-2027)
Table 62. China Bovine Blood Plasma Derivatives Sales (K Liters) by Application (2016-2021)
Table 63. China Bovine Blood Plasma Derivatives Sales Share by Application (2016-2021)
Table 64. China Bovine Blood Plasma Derivatives Revenue (US$ Million) Market Share by Application (2016-2021)
Table 65. China Bovine Blood Plasma Derivatives Price (USD/L) by Application (2016-2021)
Table 66. China Bovine Blood Plasma Derivatives Sales (K Liters) by Application (2022-2027)
Table 67. China Bovine Blood Plasma Derivatives Sales Share by Application (2022-2027)
Table 68. China Bovine Blood Plasma Derivatives Revenue (US$ Million) Market Share by Application (2022-2027)
Table 69. China Bovine Blood Plasma Derivatives Revenue Share by Application (2022-2027)
Table 70. China Bovine Blood Plasma Derivatives Price (USD/L) by Application (2022-2027)
Table 71. North America Bovine Blood Plasma Derivatives Sales by Country (2016-2021) & (K Liters)
Table 72. North America Bovine Blood Plasma Derivatives Sales Market Share by Country (2016-2021)
Table 73. North America Bovine Blood Plasma Derivatives Revenue by Country (2016-2021) & (US$ Million)
Table 74. North America Bovine Blood Plasma Derivatives Revenue Market Share by Country (2016-2021)
Table 75. Asia Pacific Bovine Blood Plasma Derivatives Sales by Region (2016-2021) & (K Liters)
Table 76. Asia Pacific Bovine Blood Plasma Derivatives Sales Market Share by Region (2016-2021)
Table 77. Asia Pacific Bovine Blood Plasma Derivatives Revenue by Region (2016-2021) & (US$ Million)
Table 78. Asia Pacific Bovine Blood Plasma Derivatives Revenue Market Share by Region (2016-2021)
Table 79. Europe Bovine Blood Plasma Derivatives Sales by Country (2016-2021) & (K Liters)
Table 80. Europe Bovine Blood Plasma Derivatives Sales Market Share by Country (2016-2021)
Table 81. Europe Bovine Blood Plasma Derivatives Revenue by Country (2016-2021) & (US$ Million)
Table 82. Europe Bovine Blood Plasma Derivatives Revenue Market Share by Country (2016-2021)
Table 83. Latin America Bovine Blood Plasma Derivatives Sales by Country (2016-2021) & (K Liters)
Table 84. Latin America Bovine Blood Plasma Derivatives Sales Market Share by Country (2016-2021)
Table 85. Latin Americaa Bovine Blood Plasma Derivatives Revenue by Country (2016-2021) & (US$ Million)
Table 86. Latin America Bovine Blood Plasma Derivatives Revenue Market Share by Country (2016-2021)
Table 87. Middle East and Africa Bovine Blood Plasma Derivatives Sales by Country (2016-2021) & (K Liters)
Table 88. Middle East and Africa Bovine Blood Plasma Derivatives Sales Market Share by Country (2016-2021)
Table 89. Middle East and Africa Bovine Blood Plasma Derivatives Revenue by Country (2016-2021) & (US$ Million)
Table 90. Middle East and Africa Bovine Blood Plasma Derivatives Revenue Market Share by Country (2016-2021)
Table 91. Thermo Fisher Corporation Information
Table 92. Thermo Fisher Description and Business Overview
Table 93. Thermo Fisher Bovine Blood Plasma Derivatives Sales (K Liters), Revenue (US$ Million), Price (USD/L) and Gross Margin (2016-2021)
Table 94. Thermo Fisher Bovine Blood Plasma Derivatives Product
Table 95. Thermo Fisher Recent Development
Table 96. GE Healthcare Corporation Information
Table 97. GE Healthcare Description and Business Overview
Table 98. GE Healthcare Bovine Blood Plasma Derivatives Sales (K Liters), Revenue (US$ Million), Price (USD/L) and Gross Margin (2016-2021)
Table 99. GE Healthcare Product
Table 100. GE Healthcare Recent Development
Table 101. Merck (Sigma-Aldrich) Corporation Information
Table 102. Merck (Sigma-Aldrich) Description and Business Overview
Table 103. Merck (Sigma-Aldrich) Bovine Blood Plasma Derivatives Sales (K Liters), Revenue (US$ Million), Price (USD/L) and Gross Margin (2016-2021)
Table 104. Merck (Sigma-Aldrich) Product
Table 105. Merck (Sigma-Aldrich) Recent Development
Table 106. Moregate BioTech Corporation Information
Table 107. Moregate BioTech Description and Business Overview
Table 108. Moregate BioTech Bovine Blood Plasma Derivatives Sales (K Liters), Revenue (US$ Million), Price (USD/L) and Gross Margin (2016-2021)
Table 109. Moregate BioTech Product
Table 110. Moregate BioTech Recent Development
Table 111. Gemini Corporation Information
Table 112. Gemini Description and Business Overview
Table 113. Gemini Bovine Blood Plasma Derivatives Sales (K Liters), Revenue (US$ Million), Price (USD/L) and Gross Margin (2016-2021)
Table 114. Gemini Product
Table 115. Gemini Recent Development
Table 116. Atlanta Biologicals Corporation Information
Table 117. Atlanta Biologicals Description and Business Overview
Table 118. Atlanta Biologicals Bovine Blood Plasma Derivatives Sales (K Liters), Revenue (US$ Million), Price (USD/L) and Gross Margin (2016-2021)
Table 119. Atlanta Biologicals Product
Table 120. Atlanta Biologicals Recent Development
Table 121. Tissue Culture Biologicals Corporation Information
Table 122. Tissue Culture Biologicals Description and Business Overview
Table 123. Tissue Culture Biologicals Bovine Blood Plasma Derivatives Sales (K Liters), Revenue (US$ Million), Price (USD/L) and Gross Margin (2016-2021)
Table 124. Tissue Culture Biologicals Product
Table 125. Tissue Culture Biologicals Recent Development
Table 126. Bovogen Corporation Information
Table 127. Bovogen Description and Business Overview
Table 128. Bovogen Bovine Blood Plasma Derivatives Sales (K Liters), Revenue (US$ Million), Price (USD/L) and Gross Margin (2016-2021)
Table 129. Bovogen Product
Table 130. Bovogen Recent Development
Table 131. Biowest Corporation Information
Table 132. Biowest Description and Business Overview
Table 133. Biowest Bovine Blood Plasma Derivatives Sales (K Liters), Revenue (US$ Million), Price (USD/L) and Gross Margin (2016-2021)
Table 134. Biowest Product
Table 135. Biowest Recent Development
Table 136. Internegocios Corporation Information
Table 137. Internegocios Description and Business Overview
Table 138. Internegocios Bovine Blood Plasma Derivatives Sales (K Liters), Revenue (US$ Million), Price (USD/L) and Gross Margin (2016-2021)
Table 139. Internegocios Product
Table 140. Internegocios Recent Development
Table 141. RMBIO Corporation Information
Table 142. RMBIO Description and Business Overview
Table 143. RMBIO Bovine Blood Plasma Derivatives Sales (K Liters), Revenue (US$ Million), Price (USD/L) and Gross Margin (2016-2021)
Table 144. RMBIO Product
Table 145. RMBIO Recent Development
Table 146. Biological Industries Corporation Information
Table 147. Biological Industries Description and Business Overview
Table 148. Biological Industries Bovine Blood Plasma Derivatives Sales (K Liters), Revenue (US$ Million), Price (USD/L) and Gross Margin (2016-2021)
Table 149. Biological Industries Product
Table 150. Biological Industries Recent Development
Table 151. VWR Corporation Information
Table 152. VWR Description and Business Overview
Table 153. VWR Bovine Blood Plasma Derivatives Sales (K Liters), Revenue (US$ Million), Price (USD/L) and Gross Margin (2016-2021)
Table 154. VWR Product
Table 155. VWR Recent Development
Table 156. Corning Corporation Information
Table 157. Corning Description and Business Overview
Table 158. Corning Bovine Blood Plasma Derivatives Sales (K Liters), Revenue (US$ Million), Price (USD/L) and Gross Margin (2016-2021)
Table 159. Corning Product
Table 160. Corning Recent Development
Table 161. Serana Corporation Information
Table 162. Serana Description and Business Overview
Table 163. Serana Bovine Blood Plasma Derivatives Sales (K Liters), Revenue (US$ Million), Price (USD/L) and Gross Margin (2016-2021)
Table 164. Serana Product
Table 165. Serana Recent Development
Table 166. Lanzhou Minhai Corporation Information
Table 167. Lanzhou Minhai Description and Business Overview
Table 168. Lanzhou Minhai Bovine Blood Plasma Derivatives Sales (K Liters), Revenue (US$ Million), Price (USD/L) and Gross Margin (2016-2021)
Table 169. Lanzhou Minhai Product
Table 170. Lanzhou Minhai Recent Development
Table 171. Zhejiang Tianhang Biotechnology Corporation Information
Table 172. Zhejiang Tianhang Biotechnology Description and Business Overview
Table 173. Zhejiang Tianhang Biotechnology Bovine Blood Plasma Derivatives Sales (K Liters), Revenue (US$ Million), Price (USD/L) and Gross Margin (2016-2021)
Table 174. Zhejiang Tianhang Biotechnology Product
Table 175. Zhejiang Tianhang Biotechnology Recent Development
Table 176. ExCell Bio Corporation Information
Table 177. ExCell Bio Description and Business Overview
Table 178. ExCell Bio Bovine Blood Plasma Derivatives Sales (K Liters), Revenue (US$ Million), Price (USD/L) and Gross Margin (2016-2021)
Table 179. ExCell Bio Product
Table 180. ExCell Bio Recent Development
Table 181. Jin Yuan Kang Corporation Information
Table 182. Jin Yuan Kang Description and Business Overview
Table 183. Jin Yuan Kang Bovine Blood Plasma Derivatives Sales (K Liters), Revenue (US$ Million), Price (USD/L) and Gross Margin (2016-2021)
Table 184. Jin Yuan Kang Product
Table 185. Jin Yuan Kang Recent Development
Table 186. American Protein Company Corporation Information
Table 187. American Protein Company Description and Business Overview
Table 188. American Protein Company Bovine Blood Plasma Derivatives Sales (K Liters), Revenue (US$ Million), Price (USD/L) and Gross Margin (2016-2021)
Table 189. American Protein Company Product
Table 190. American Protein Company Recent Development
Table 191. Sonac Corporation Information
Table 192. Sonac Description and Business Overview
Table 193. Sonac Bovine Blood Plasma Derivatives Sales (K Liters), Revenue (US$ Million), Price (USD/L) and Gross Margin (2016-2021)
Table 194. Sonac Product
Table 195. Sonac Recent Development
Table 196. Bovine Blood Plasma Derivatives Market Trends
Table 197. Bovine Blood Plasma Derivatives Market Drivers
Table 198. Bovine Blood Plasma Derivatives Market Challenges
Table 199. Bovine Blood Plasma Derivatives Market Restraints
Table 200. Bovine Blood Plasma Derivatives Customers List
Table 201. Bovine Blood Plasma Derivatives Distributors List
Table 202. Research Programs/Design for This Report
Table 203. Key Data Information from Secondary Sources
Table 204. Key Data Information from Primary Sources
List of Figures
Figure 1. Bovine Blood Plasma Derivatives Product Picture
Figure 2. Global Bovine Blood Plasma Derivatives Sales Market Share by Type in 2020 & 2027
Figure 3. Bovine Serum Product Picture
Figure 4. FBS Product Picture
Figure 5. Bovine Serum Albumin Product Picture
Figure 6. Fibrinogen Product Picture
Figure 7. Protein Ingredient Product Picture
Figure 8. Other Product Picture
Figure 9. Global Bovine Blood Plasma Derivatives Sales Market Share by Application in 2020 & 2027
Figure 10. Scientific Research
Figure 11. Industrial Production
Figure 12. Feed
Figure 13. Others
Figure 14. Bovine Blood Plasma Derivatives Report Years Considered
Figure 15. Global Bovine Blood Plasma Derivatives Market Size, (US$ Million), 2016 VS 2021 VS 2027
Figure 16. Global Bovine Blood Plasma Derivatives Market Size 2016-2027 (US$ Million)
Figure 17. Global Bovine Blood Plasma Derivatives Sales 2016-2027 (K Liters)
Figure 18. Global Bovine Blood Plasma Derivatives Market Size Market Share by Region: 2021 Versus 2027
Figure 19. Global Bovine Blood Plasma Derivatives Sales Market Share by Region (2016-2021)
Figure 20. Global Bovine Blood Plasma Derivatives Sales Market Share by Region in 2020
Figure 21. Global Bovine Blood Plasma Derivatives Revenue Market Share by Region (2016-2021)
Figure 22. Global Bovine Blood Plasma Derivatives Revenue Market Share by Region in 2020
Figure 23. Global Bovine Blood Plasma Derivatives Sales Share by Manufacturer in 2020
Figure 24. The Top 10 and 5 Players Market Share by Bovine Blood Plasma Derivatives Revenue in 2020
Figure 25. Bovine Blood Plasma Derivatives Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 26. Global Bovine Blood Plasma Derivatives Sales Market Share by Type (2016-2021)
Figure 27. Global Bovine Blood Plasma Derivatives Sales Market Share by Type in 2020
Figure 28. Global Bovine Blood Plasma Derivatives Revenue Market Share by Type (2016-2021)
Figure 29. Global Bovine Blood Plasma Derivatives Revenue Market Share by Type in 2020
Figure 30. Global Bovine Blood Plasma Derivatives Sales Market Share by Application (2016-2021)
Figure 31. Global Bovine Blood Plasma Derivatives Sales Market Share by Application in 2020
Figure 32. Global Bovine Blood Plasma Derivatives Revenue Market Share by Application (2016-2021)
Figure 33. Global Bovine Blood Plasma Derivatives Revenue Market Share by Application in 2020
Figure 34. China Bovine Blood Plasma Derivatives Sales Growth Rate 2016-2027 (K Liters)
Figure 35. China Bovine Blood Plasma Derivatives Revenue Growth Rate 2016-2027 (US$ Million)
Figure 36. China Bovine Blood Plasma Derivatives Market Share in Global Market 2016-2027
Figure 37. China 5 and 10 Largest Bovine Blood Plasma Derivatives Players Market Share by Revenue in Bovine Blood Plasma Derivatives in 2020
Figure 38. China Bovine Blood Plasma Derivatives Revenue Share by Type (2016-2021)
Figure 39. China Bovine Blood Plasma Derivatives Revenue Growth Rate by Type in 2016 & 2020
Figure 40. China Bovine Blood Plasma Derivatives Revenue Share by Application (2016-2021)
Figure 41. China Bovine Blood Plasma Derivatives Revenue Growth Rate by Application in 2016 & 2020
Figure 42. North America Bovine Blood Plasma Derivatives Sales Growth Rate 2016-2021 (K Liters)
Figure 43. North America Bovine Blood Plasma Derivatives Revenue Growth Rate 2016-2021 (US$ Million)
Figure 44. North America Bovine Blood Plasma Derivatives Sales Market Share by Country in 2020
Figure 45. North America Bovine Blood Plasma Derivatives Revenue Market Share by Country in 2020
Figure 46. U.S. Bovine Blood Plasma Derivatives Sales Growth Rate (2016-2021) (K Liters)
Figure 47. U.S. Bovine Blood Plasma Derivatives Revenue Growth Rate (2016-2021) (US$ Million)
Figure 48. Canada Bovine Blood Plasma Derivatives Sales Growth Rate (2016-2021) (K Liters)
Figure 49. Canada Bovine Blood Plasma Derivatives Revenue Growth Rate (2016-2021) (US$ Million)
Figure 50. Europe Bovine Blood Plasma Derivatives Sales Growth Rate 2016-2021 (K Liters)
Figure 51. Europe Bovine Blood Plasma Derivatives Revenue Growth Rate 2016-2021 (US$ Million)
Figure 52. Europe Bovine Blood Plasma Derivatives Sales Market Share by Country in 2020
Figure 53. Europe Bovine Blood Plasma Derivatives Revenue Market Share by Country in 2020
Figure 54. Germany Bovine Blood Plasma Derivatives Sales Growth Rate (2016-2021) (K Liters)
Figure 55. Germany Bovine Blood Plasma Derivatives Revenue Growth Rate (2016-2021) (US$ Million)
Figure 56. France Bovine Blood Plasma Derivatives Sales Growth Rate (2016-2021) (K Liters)
Figure 57. France Bovine Blood Plasma Derivatives Revenue Growth Rate (2016-2021) (US$ Million)
Figure 58. U.K. Bovine Blood Plasma Derivatives Sales Growth Rate (2016-2021) (K Liters)
Figure 59. U.K. Bovine Blood Plasma Derivatives Revenue Growth Rate (2016-2021) (US$ Million)
Figure 60. Italy Bovine Blood Plasma Derivatives Sales Growth Rate (2016-2021) (K Liters)
Figure 61. Italy Bovine Blood Plasma Derivatives Revenue Growth Rate (2016-2021) (US$ Million)
Figure 62. Russia Bovine Blood Plasma Derivatives Sales Growth Rate (2016-2021) (K Liters)
Figure 63. Russia Bovine Blood Plasma Derivatives Revenue Growth Rate (2016-2021) (US$ Million)
Figure 64. Asia Pacific Bovine Blood Plasma Derivatives Sales Growth Rate 2016-2021 (K Liters)
Figure 65. Asia Pacific Bovine Blood Plasma Derivatives Revenue Growth Rate 2016-2021 (US$ Million)
Figure 66. Asia Pacific Bovine Blood Plasma Derivatives Sales Market Share by Region in 2020
Figure 67. Asia Pacific Bovine Blood Plasma Derivatives Revenue Market Share by Region in 2020
Figure 68. China Bovine Blood Plasma Derivatives Sales Growth Rate (2016-2021) (K Liters)
Figure 69. China Bovine Blood Plasma Derivatives Revenue Growth Rate (2016-2021) (US$ Million)
Figure 70. Japan Bovine Blood Plasma Derivatives Sales Growth Rate (2016-2021) (K Liters)
Figure 71. Japan Bovine Blood Plasma Derivatives Revenue Growth Rate (2016-2021) (US$ Million)
Figure 72. South Korea Bovine Blood Plasma Derivatives Sales Growth Rate (2016-2021) (K Liters)
Figure 73. South Korea Bovine Blood Plasma Derivatives Revenue Growth Rate (2016-2021) (US$ Million)
Figure 74. India Bovine Blood Plasma Derivatives Sales Growth Rate (2016-2021) (K Liters)
Figure 75. India Bovine Blood Plasma Derivatives Revenue Growth Rate (2016-2021) (US$ Million)
Figure 76. Australia Bovine Blood Plasma Derivatives Sales Growth Rate (2016-2021) (K Liters)
Figure 77. Australia Bovine Blood Plasma Derivatives Revenue Growth Rate (2016-2021) (US$ Million)
Figure 78. Taiwan Bovine Blood Plasma Derivatives Sales Growth Rate (2016-2021) (K Liters)
Figure 79. Taiwan Bovine Blood Plasma Derivatives Revenue Growth Rate (2016-2021) (US$ Million)
Figure 80. Indonesia Bovine Blood Plasma Derivatives Sales Growth Rate (2016-2021) (K Liters)
Figure 81. Indonesia Bovine Blood Plasma Derivatives Revenue Growth Rate (2016-2021) (US$ Million)
Figure 82. Thailand Bovine Blood Plasma Derivatives Sales Growth Rate (2016-2021) (K Liters)
Figure 83. Thailand Bovine Blood Plasma Derivatives Revenue Growth Rate (2016-2021) (US$ Million)
Figure 84. Malaysia Bovine Blood Plasma Derivatives Sales Growth Rate (2016-2021) (K Liters)
Figure 85. Malaysia Bovine Blood Plasma Derivatives Revenue Growth Rate (2016-2021) (US$ Million)
Figure 86. Philippines Bovine Blood Plasma Derivatives Sales Growth Rate (2016-2021) (K Liters)
Figure 87. Philippines Bovine Blood Plasma Derivatives Revenue Growth Rate (2016-2021) (US$ Million)
Figure 88. Vietnam Bovine Blood Plasma Derivatives Sales Growth Rate (2016-2021) (K Liters)
Figure 89. Vietnam Bovine Blood Plasma Derivatives Revenue Growth Rate (2016-2021) (US$ Million)
Figure 90. Latin America Bovine Blood Plasma Derivatives Sales Growth Rate 2016-2021 (K Liters)
Figure 91. Latin America Bovine Blood Plasma Derivatives Revenue Growth Rate 2016-2021 (US$ Million)
Figure 92. Latin America Bovine Blood Plasma Derivatives Sales Market Share by Country in 2020
Figure 93. Latin America Bovine Blood Plasma Derivatives Revenue Market Share by Country in 2020
Figure 94. Mexico Bovine Blood Plasma Derivatives Sales Growth Rate (2016-2021) (K Liters)
Figure 95. Mexico Bovine Blood Plasma Derivatives Revenue Growth Rate (2016-2021) (US$ Million)
Figure 96. Brazil Bovine Blood Plasma Derivatives Sales Growth Rate (2016-2021) (K Liters)
Figure 97. Brazil Bovine Blood Plasma Derivatives Revenue Growth Rate (2016-2021) (US$ Million)
Figure 98. Argentina Bovine Blood Plasma Derivatives Sales Growth Rate (2016-2021) (K Liters)
Figure 99. Argentina Bovine Blood Plasma Derivatives Revenue Growth Rate (2016-2021) (US$ Million)
Figure 100. Middle East and Africa Bovine Blood Plasma Derivatives Sales Growth Rate 2016-2021 (K Liters)
Figure 101. Middle East and Africa Bovine Blood Plasma Derivatives Revenue Growth Rate 2016-2021 (US$ Million)
Figure 102. Middle East and Africa Bovine Blood Plasma Derivatives Sales Market Share by Country in 2020
Figure 103. Middle East and Africa Bovine Blood Plasma Derivatives Revenue Market Share by Country in 2020
Figure 104. Turkey Bovine Blood Plasma Derivatives Sales Growth Rate (2016-2021) (K Liters)
Figure 105. Turkey Bovine Blood Plasma Derivatives Revenue Growth Rate (2016-2021) (US$ Million)
Figure 106. Saudi Arabia Bovine Blood Plasma Derivatives Sales Growth Rate (2016-2021) (K Liters)
Figure 107. Saudi Arabia Bovine Blood Plasma Derivatives Revenue Growth Rate (2016-2021) (US$ Million)
Figure 108. U.A.E Bovine Blood Plasma Derivatives Sales Growth Rate (2016-2021) (K Liters)
Figure 109. U.A.E Bovine Blood Plasma Derivatives Revenue Growth Rate (2016-2021) (US$ Million)
Figure 110. Bovine Blood Plasma Derivatives Value Chain
Figure 111. Channels of Distribution
Figure 112. Distributors Profiles
Figure 113. Bottom-up and Top-down Approaches for This Report
Figure 114. Data Triangulation
Figure 115. Key Executives Interviewed
生命科学用ウシ胎児血清の世界市場 2020年 Market Overview The Fetal Bovine Serum for Life Sciences market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chai…- ウシ胎児血清（FBS）の世界市場 2020年 Market Overview The global Fetal Bovine Serum (FBS) market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Fetal Bovine Serum (…
- フォーミュラフェッド牛血清の世界市場 2020年 Market Overview The global Formula Fed Bovine Serum market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Formula Fed Bovine S…
- 成牛血清の世界市場 2020年 Market Overview The global Adult Bovine Serum market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Adult Bovine Serum market …
- 新生牛血清の世界市場 2020年 Market Overview The global Newborn Bovine Serum market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Newborn Bovine Serum mar…